Recovery of Vα24+ NKT cells after hematopoietic stem cell transplantation

Bone Marrow Transplantation

Volumn 34, Issue 7, 2004, Pages 595-602

  Haraguchi, K ^a,b,c   Takahashi, T ^a   Hiruma, K ^b   Kanda, Y ^a   Tanaka, Y ^b   Ogawa, S ^a   Chiba, S ^a   Miura, O ^c   Sakamaki, H ^b   Hirai, H ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

GVHD; Immune reconstitution; NKT cells

Indexed keywords

ALEMTUZUMAB; CD4 ANTIGEN; CYCLOSPORIN; METHOTREXATE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; TACROLIMUS; THYMOCYTE ANTIBODY; LYMPHOCYTE ANTIGEN RECEPTOR;

ACUTE DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; APLASTIC ANEMIA; ARTICLE; CHRONIC DISEASE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; RECIPIENT; T CELL LEUKEMIA; ADOLESCENT; BONE MARROW TRANSPLANTATION; CONVALESCENCE; DONOR; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE SYSTEM; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECOVERY OF FUNCTION; TISSUE DONORS;

EID: 5044242798     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704582     Document Type: Article

References (34)

1. Fujimaki K, Maruta A, Yoshida M et al. Immune reconstitution assessed during five years after allogeneic bone marrow transplantation. Bone Marrow Transplant 2001; 27: 1275-1281.
2. Storek J, Dawson MA, Storer B et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001; 97: 3380-3389.
3. Fowlkes BJ, Kruisbeek AM, Ton-That H et al. A novel population of T cell receptor αβ-bearing thymocytes which predominantly express a single Vβ8 gene family. Nature 1987; 329: 251-254.
4. Budd RC, Miescher GC, Howe RC et al. Developmentally regulated expression of T cell receptor β chain variable domain is immature thymocytes. J Exp Med 1987; 166: 577-582.
5. -T cells in mice and humans. J Exp Med 1994; 180: 1097-1106.
6. - cells. J Exp Med 1994; 180: 1171-1176.
7. - and heterogeneous with respect to TCRβ expression. Hum Immunol 1996; 48: 63-67.
8. Godfrey DI, Hammond KJL, Poulton LD, Baxter AG. NKT cells: facts, functions and fallacies. Immunol Today 2000; 21: 573-583.
9. Joyce S. CD1d and natural T cells: how their properties jump-start the immune system. Cell Mol Life Sci 2001; 58: 442-469.
10. + T cells reciprocally regulate acute graft versus host disease. J Exp Med 1999; 189: 1073-1081.
11. + natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon γ production. Blood 2001; 97: 2923-2931.
12. Thiede C, Florek M, Bornhäuser M et al. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplant 1999; 23: 1055-1060.
13. + NKT cells activated by α -galactosylceramide-pulsed monocyte-derived dendritic cells. J Immunol 2000; 164: 4458-4464.
14. + NKT Cells activated by α -galactosylceramide-pulsed monocyte-derived dendritic cells. J Immunol 2002; 168: 3140-3144.
15. Karadimitris A, Gadola S, Altamirano M et al. Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc Natl Acad Sci USA 2001; 98: 3294-3298.
16. Lee PT, Benlagha K, Teyton L, Bendelac A. Distinct functional lineages of human Vα24 natural killer T cells. J Esp Med 2002; 195: 637-641.
17. Exley MA, Tahir SMA, Cheng O et al. A major fraction of human bone marrow lymphocyte are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses. J Immunol 2001; 167: 5531-5534.
18. + NKT cell subsets with distinct cytokine-producing capacity. Blood 2002; 100: 11-16.
19. Sonoda K, Exley M, Snapper S et al. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J Exp Med 1999; 190: 1215-1225.
20. Seino K, Fukao K, Muramoto K et al. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci USA 2001; 98: 2577-2581.
21. Chargui J, Hase T, Wada S et al. NKT cells as nonspecific immune-regulator inducing tolerance in mouse model transplantation. Transplant Proc 2001; 33: 3833-3834.
22. Higuchi M, Zeng D, Shizuru J et al. Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NKT cells and clonal deletion. J Immunol 2002; 169: 5564-5570.
23. + Vα24 natural killer T cells are essential for acceptance of rat islet xenografts in mice. J Clin Invest 2000; 105: 1761-1767.
24. Gumperz JE, Miyake S, Yamamura T, Brenner MB. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 2002; 195: 625-636.
25. Teshima T, Ferrara JLM. Understanding the alloresponse: new approaches to graft-versus-host disease prevention. Semin Hematol 2002; 39: 15-22.
26. Ellison CA, Fischer JMM, HayGlass KT, Gartner JG. Murine graft-versus-host disease in an F1-hybrid model using IFN-α gene knockout donors. J Immunol 1998; 161: 631 640.
27. Allen RD, Staley TA, Sidman CL. Differential cytokine expression in acute and chronic murine grart-versus-host-disease. Eur J Immunol 1993; 23: 333-337.
28. Brok HPM, Heidt PJ, van der Meide PH et al. Interferon-γ prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Immunol 1993; 151: 6451-6459.
29. Yang YG, Dey BR, Sergio JJ et al. Donor-derived interferon γ is required for inhibition of acute graft-versus-host disease by interleukin 12. J Clin Invest 1998; 102: 2126-2135.
30. Murphy WJ, Welniak LA, Taub DD et al. Differential effects of the absence of interferon-γ and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Clin Invest 1998; 102: 1742-1748.
31. + T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: 'natural suppressor' cells. J Immunol 2001; 167: 2087-2096.
32. + natural killer T cells are markedly decreased in atopic dermatitis patients. Hum Immunol 2003; 64: 586-592.
33. Sonoda K, Faunce DE, Taniguchi M et al. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J Immunol 2001; 166: 42-50.
34. + immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002; 99: 3493-3499.